Recombinant LEPR (Mibavademab Biosimilar) antibody

Catalog No. ABIN7581547

The Human Monoclonal anti-LEPR (Mibavademab Biosimilar) antibody has been validated for ELISA, FACS, BLI, Func and SPR. It is suitable to detect LEPR (Mibavademab Biosimilar) in samples from Human.

Quick Overview for Recombinant LEPR (Mibavademab Biosimilar) antibody (ABIN7581547)

Target: LEPR (Mibavademab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This LEPR (Mibavademab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-LEPR (Mibavademab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-LEPR / CD295 Reference Antibody (mibavademab)

Characteristics: Anti-LEPR / CD295 Reference Antibody (mibavademab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG4 S228P

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for LEPR (Mibavademab Biosimilar)

Target: LEPR (Mibavademab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P48357